TLRY
Tilray Inc
NASDAQ: TLRY · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$6.24
+1.63% today
Updated 2026-04-30
Market cap
$784.60M
P/E ratio
—
P/S ratio
0.91x
EPS (TTM)
$-14.63
Dividend yield
—
52W range
$4 – $23
Volume
4.5M
Tilray Inc (TLRY) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$6.24
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$30.78
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.6B | $0.8B | $0.8B | $1.1B | $1.1B | $1.4B | $1.6B | $1.9B | $2.3B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -156.70%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.